Skip to main content
. 2021 Feb 5;2021(2):CD013534. doi: 10.1002/14651858.CD013534.pub2

NCT03871998.

Study name Short‐term Topical Application to Prevent Atopic Dermatitis (STOP AD)
Methods Single‐centre, randomised, open‐label, controlled study 
Participants 242 participants
Interventions Experimental: intervention arm
Skin barrier protection in the first 2 months of life
No intervention: control arm
Standard skin care advice. No moisturiser in the first 2 months
Outcomes Primary outcomes
  1. Cumulative incidence of atopic dermatitis at 12 months [Time Frame: 12 months]

  2. Cumulative incidence of IgE‐mediated food allergy at 2 years [Time Frame: 2 years]


Secondary outcomes
  1. Longitudinal changes in transepidermal water loss (TEWL) from birth to 12 months [Time Frame: Birth to 12 months]

  2. Longitudinal changes in natural moisturising factor (NMF) in the stratum corneum from birth to 12 months [Time Frame: Birth to 12 months]

  3. Microbial diversity and richness of the cheek and antecubital fossa (study subset) [Time Frame: Skin swabs for microbiome analysis will be taken at baseline (0 to 4 days), 8 weeks, and 12 months]

  4. Changes in skin microbial diversity and richness over the first year of life [Time Frame: Skin swabs for microbiome analysis will be taken at baseline (0 to 4 days), 8 weeks, and 12 months]

  5. Comparison of microbial diversity and richness between intervention and control groups [Time Frame: Skin swabs for microbiome analysis will be taken at baseline (0 to 4 days), 8 weeks, and 12 months]

  6. Skin biomarker profile analysis of the cheek and antecubital fossa (study subset) [Time Frame: Skin swabs for biomarker analysis will be taken at baseline (0 to 4 days), 8 weeks, and 12 months]

  7. Changes in skin biomarker profile between studies over the first year of life [Time Frame: Skin swabs for biomarker analysis will be taken at baseline (0 to 4 days), 8 weeks, and 12 months]

  8. Comparison of skin biomarker profiles between intervention and control groups [Time Frame: Skin swabs for biomarker analysis will be taken at baseline (0 to 4 days), 8 weeks, and 12 months]

Starting date 12 March 2019
Contact information Carol Ní Chaoimh ‐ cnichaoimh@ucc.ie
Mairead Murray ‐ mairead.murray@ucc.ie
Notes